<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15</volume><submitter>Akgun-Dogan O</submitter><pubmed_abstract>&lt;b>Background:&lt;/b> Pediatric patients with undiagnosed conditions, particularly those suspected of having Mendelian genetic disorders, pose a significant challenge in healthcare. This study investigates the diagnostic yield of whole-genome sequencing (WGS) in a pediatric cohort with diverse phenotypes, particularly focusing on the role of clinical expertise in interpreting WGS results. &lt;b>Methods:&lt;/b> A retrospective cohort study was conducted at Acibadem University's Maslak Hospital in Istanbul, Turkey, involving pediatric patients (0-18 years) who underwent diagnostic WGS testing. Clinical assessments, family histories, and previous laboratory and imaging studies were analyzed. Variants were classified and interpreted in conjunction with clinical findings. &lt;b>Results:&lt;/b> The cohort comprised 172 pediatric patients, aged 0-5 years (62.8%). International patients (28.5%) were from 20 different countries. WGS was used as a first-tier approach in 61.6% of patients. The diagnostic yield of WGS reached 61.0%, enhanced by reclassification of variants of uncertain significance (VUS) through reverse phenotyping by an experienced clinical geneticist. Consanguinity was 18.6% of the overall cohort. Dual diagnoses were carried out for 8.5% of solved patients. &lt;b>Discussion:&lt;/b> Our study particularly advocates for the selection of WGS as a first-tier testing approach in infants and children with rare diseases, who were under 5 years of age, thereby potentially shortening the duration of the diagnostic odyssey. The results also emphasize the critical role of a single clinical geneticist's expertise in deep phenotyping and reverse phenotyping, which contributed significantly to the high diagnostic yield.</pubmed_abstract><journal>Frontiers in genetics</journal><pagination>1347474</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10978702</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Impact of deep phenotyping: high diagnostic yield in a diverse pediatric population of 172 patients through clinical whole-genome sequencing at a single center.</pubmed_title><pmcid>PMC10978702</pmcid><pubmed_authors>Akgun-Dogan O</pubmed_authors><pubmed_authors>Tuc Bengur E</pubmed_authors><pubmed_authors>Bulut AS</pubmed_authors><pubmed_authors>Ay B</pubmed_authors><pubmed_authors>Alanay Y</pubmed_authors><pubmed_authors>Kar E</pubmed_authors><pubmed_authors>Bengur FB</pubmed_authors><pubmed_authors>Yigit A</pubmed_authors><pubmed_authors>Aydin E</pubmed_authors><pubmed_authors>Esen FN</pubmed_authors><pubmed_authors>Ozkose GS</pubmed_authors><pubmed_authors>Ozdemir O</pubmed_authors><pubmed_authors>Yesilyurt A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of deep phenotyping: high diagnostic yield in a diverse pediatric population of 172 patients through clinical whole-genome sequencing at a single center.</name><description>&lt;b>Background:&lt;/b> Pediatric patients with undiagnosed conditions, particularly those suspected of having Mendelian genetic disorders, pose a significant challenge in healthcare. This study investigates the diagnostic yield of whole-genome sequencing (WGS) in a pediatric cohort with diverse phenotypes, particularly focusing on the role of clinical expertise in interpreting WGS results. &lt;b>Methods:&lt;/b> A retrospective cohort study was conducted at Acibadem University's Maslak Hospital in Istanbul, Turkey, involving pediatric patients (0-18 years) who underwent diagnostic WGS testing. Clinical assessments, family histories, and previous laboratory and imaging studies were analyzed. Variants were classified and interpreted in conjunction with clinical findings. &lt;b>Results:&lt;/b> The cohort comprised 172 pediatric patients, aged 0-5 years (62.8%). International patients (28.5%) were from 20 different countries. WGS was used as a first-tier approach in 61.6% of patients. The diagnostic yield of WGS reached 61.0%, enhanced by reclassification of variants of uncertain significance (VUS) through reverse phenotyping by an experienced clinical geneticist. Consanguinity was 18.6% of the overall cohort. Dual diagnoses were carried out for 8.5% of solved patients. &lt;b>Discussion:&lt;/b> Our study particularly advocates for the selection of WGS as a first-tier testing approach in infants and children with rare diseases, who were under 5 years of age, thereby potentially shortening the duration of the diagnostic odyssey. The results also emphasize the critical role of a single clinical geneticist's expertise in deep phenotyping and reverse phenotyping, which contributed significantly to the high diagnostic yield.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2026-05-22T03:10:44.919Z</modification><creation>2025-04-06T07:46:13.426Z</creation></dates><accession>S-EPMC10978702</accession><cross_references><pubmed>38560291</pubmed><doi>10.3389/fgene.2024.1347474</doi></cross_references></HashMap>